Physician profile
Guillermo A Pasarin
NPI 1669467924
$2,902.61
in general payments reported to CMS, 2019-2025
41 companies · $19.23 in 2025
The $19.23 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $407 · 2021: $548 · 2022: $692 · 2023: $494 · 2024: $178 · 2025: $19.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $717.14 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $361.54 | 2020-2022 | |
| Medtronic, INC. | $330.28 | 2022-2023 | Endoskeleton Tc Nanolock Surface Technology, Unid_pass |
| Abbvie INC. | $165.73 | 2022-2024 | |
| Nuvasive, INC. | $117.63 | 2020-2023 | Simplify Cervical Artificial Disc, Modulus, Reline |
| Csl Behring | $93.10 | 2022 | |
| Integra Lifesciences Corporation | $77.34 | 2024 | Microfrance, Integra Duo, Codman Isocool Aht |
| Sunovion Pharmaceuticals INC. | $74.53 | 2019-2022 | |
| Octapharma USA, INC. | $72.42 | 2022-2023 | Panzyga |
| Depuy Synthes Sales INC. | $67.82 | 2019-2021 | |
| Lundbeck LLC | $63.84 | 2021-2022 | |
| Medtronic USA, INC. | $58.92 | 2019 | |
| Celgene Corporation | $58.44 | 2021 | |
| Ucb, INC. | $50.21 | 2021 | |
| Centinel Spine, LLC | $44.45 | 2019-2023 | Prodisc C Vivo |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guillermo Pasarin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.